Cancer cells overexpress the epidermal growth factor (EGFR), so Wang et al. used epitope imprinting to prepare dual-template MIP-NPs with EGFR and doxorubicin (DOX) for targeted imaging and targeted therapy [83]. Here, EGFR is linked to cancer.